1 / 49

Neurocritical Care

Neurocritical Care. Introduction. Life threatening deterioration occurs most often within first 48 hours after onset of symptoms in patients with MCA stroke.

madge
Download Presentation

Neurocritical Care

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Neurocritical Care

  2. Introduction • Life threatening deterioration occurs most often within first 48 hours after onset of symptoms in patients with MCA stroke. • Patients should be closely monitored (continuous ECG, pulse oximetry, frequent NBP, hourly neurologic checks for the first 24-48 hours after the insult

  3. Need for ICU/HDU • Reduced or rapidly deteriorating consciousness • Ventilatory support • Control of HTN with infusions • Hypotension • Comorbidities (OSA, COPD with hypoxia, ACS, uncontrolled DM, CKD V.

  4. Diagnosis & Monitoring

  5. Initial Assessment • Airway, Breathing, Circulation • Glasgow Coma Scale • Pupillary size & reaction • History

  6. Initial Resuscitation • Restore – Ventilation - Oxygenation - Circulating Volume - Blood Pressure - Avoid Secondary Insult

  7. BASIC NEURO CRITICAL ISSUES RESPIRATORY PROTECTION CARDIOVASCULAR PROTECTION EUVOLEMIA IN  ICP HYPERVOLEMIA IN ISCHAEMIA/ USE ISOTONIC & OCCASIONALLY ISOTONIC SOLUTIONS KEEP MABP AT 100-120 mm Hg RENAL HOMEOSTASIS K > 4.0 meq/L Ca > 8.5 meq/L Phosphorus > 2.5 mg/dl Magnesium > 0.2 mg/dl PAIN ALLEVIATION Morphine 2-4 ml / 4 hrly Midazolam 0.1 mg / kg in divided doses Olanzapine 5-10 mg BD Ativan 1-2 mg QID 12/1M/ORAL

  8. Basic Monitoring • Basic monitoring – ECG, SpO2, NBP for 24 hours • Neuro Exam every hour for 24-48 hours & then according to clinical course. • Urinary Catheter for monitoring urine output & facilitating nursing care

  9. Oxygenation & Ventilation • Nasal cannula (max 4lit/min to avoid mucosal damage, O2 mask (> 6lit/min to avoid CO2 rebreathing. • NIV • Intubation for declining consciousness • Head of bed raised 30 degree • Regular mouth care with chlorhexidine

  10. Intubation & Tracheostomy • Early Tracheostomy if brain stem lesions, large hemisphere infarctions or hemorrhages who are unlikely to regain protective airway reflexes within 2 weeks • Inpatients with reduced level of consciuosness but preserved protective airway reflexes (coughing & gaging) in whom clearing of secretions seems possible, an extubation trial may be attempted even if GCS is low

  11. NEUROLOGICAL & SYSTEMIC MONITORING • SERIAL NEUROLOGIC EXAMINATION • MULTIMODALITY NEURO-MONITORING (Andrews 2000, Casteillo 2001) A. NON BRAIN MONITORING BP CONTINUOUS CORE BODY TEMP ABG B. BRAIN MONITORING ICP WHOLE BRAIN MONITORING ELECTRICAL VENOUS O2 CBFV REGIONAL CBF METABOLISM O2

  12. Electrolytes • Isotonic full electrolyte for maintenance • K monitored frequently • Diabetes Insipidus – desmopressin • SIADH & Cerebral Salt Wasting is difficult to differentiate. Sodium replenishment with isotonic/hypertonic saline is often started empirically.

  13. Fever & Temperature Control

  14. Seizure Prophylaxis • Documented seizures treated aggressively with benzodiazepines & barbiturates • Phenytoin or levetiracetam prophylaxis only in patients with clinical seizures or suspicion on EEG • Phenytoin is associated with skin reactions & drug fever. Enterally given 30 min after feeds for adequate absorption.

  15. WHOLE BRAIN MONITORING INTRACRANIAL PRESSURE (ICP) MONRO-KELLIE DOCTRINE NORMAL MEAN ICP UPTO 10mm Hg ICP THRESH HOLD FOR THERAPY 20mm Hg CEREBRAL PERFUSION PRESSURE (CPP=70~200) CPP IS VITAL CPP IS DETERMINED BY ICP & MABP CPP = MABP – ICP CPP TO BE KEPT ABOVE 70 mm Hg. REGULAR VENOUS OXYMETRY ELECTRICAL MONITORING

  16. Cerebral Blood Flow • CBF is relatively constant over MAP 60-150 mm Hg • CPP of 60-90 mm Hg provides appropriate CBF • In acute cerebral injury CPP < 60 decreases CBF & cause cerebral ischemia. Increase in CPP > 80 may increase CBF & cause vasogenic edema & increased ICP • When CBF decreases below 20ml/100g/min electrical & chemical cellular functions are interrupted & ischemic symptoms develop

  17. BASIC CRITICAL CARE APPROACH SECURE ABC CAUTIONS DURING ENDOTRACHEAL INTUBATION CERVICAL SPINE INSTABILITY IF ANY CONCERN OF AGGRAVATING ICP (RAPID SEQUENCE INTUBATION) NEUROPROTECTION GLUCOSE 80-120 mg / dl ( Rodorf 2000) KEEP CORE BODY TEMP < 37.5 C INSTITUTE EARLY NUTRITION /HYDRATION

  18. ISSUE OF ed ICP • NORMAL ICP 5 – 10 mm Hg • DETERMINANTS OF NORMAL ICP Monro kelle phenomena Volumes of - Brain - CBF - CSF • MANAGEMENT (Saurez 1999) Medical vs Surgical.

  19. Indication of ICP monitoring • GCS 3-8 • Abnormal CT • Normal CT with age >40 • BP <90

  20. MEDICAL MANAGEMENT FOR ELEVATED INTRACRANIAL PRESSURE (ICP) • Head up position at 30o • Neck in a straight position • No ETT tape ties compressing jugular veins • Gentle Chest Physiotherapy • Minimum PEEP

  21. MEDICAL MANAGEMENT FOR ELEVATED INTRACRANIAL PRESSURE (ICP) CORRECTION OF FACTORS EXACERBATING ICP HYPERCARBIA (aim PaCO2 34-37) HYPOXIA (aim PaO2>100) HYPERTHERMIA (<37o C) ACIDOSIS HYPERTENSION (150-160/90-100) HYPERVOLEMIA

  22. MEDICAL MANAGEMENT FOR ELEVATED ICP • Endotracheal Intubation & Mechanical Ventilation if - Glasgow coma scale <8 -  ICP - Respiratory instability • Controlled Hyperventilation to a PCO2 of 28-33 (if Herniating) otherwise normocapnia • Sedation & Paralysis

  23. Spontaneous or Induced Hyperventilation • Causes cerebral vasoconstriction • This decreases cerebral blood volume & ICP • A steady state is established in 3-4 hours • Excessive hypocapnia may cause excessive vasoconstriction & cerebral ischemia • Rapid return to baseline PCO2 may produce cerebral vasodilatation causing increased CBV & rise in ICP • Lack of response to hyperventilation is a poor prognostic sign

  24. Medications that Influence ICP • Vasodilators (NTG, SNP, Hydralaine) can induce cerebral vasodilation & increase ICP • Labetalol & Propranolol have minimal minimal effect on CBF & ICP • Labetalol may reduce sympathetically mediated large vessel vasoconstriction • Barbiturates(Thiopental & Phenobarbitone) lower ICP but decrease BP

  25. Medications that Influence ICP • Catecholamines increase cerebral metabolic rate & CBF • RL is hypoosmolar & may exacerbate brain edema in the setting of osmotic diuretic therapy • Glucose solutions may produce hyperglycemia

  26. MEDICAL MANAGEMENT FOR ELEVATED INTRACRANIAL PRESSURE (ICP) • Osmotherapy (Goal : Dehydrate brain not the patient) Mannitol (20%) 0.25-1 gm/kg over 30-60 minutes 4-6 hrly Monitor - Chemical status - ICP measures - Serum osmolality (300-320) - Osmolar gap > 15 - Volume status Looses effect if Osm >320 & Na >160 • Fluid restriction Choice fluid Isotonic saline Not Glucose • Replacement of urinary loss with NS in those receiving mannitol • Reduce gradually to permit excretion of idiogenic osmoles

  27. OSMOTHERAPY : MANNITOL • The good, bad, ugly and unknown about it • The dilemma persists • Is it all about timing? • Is monitoring essential? • Osmolality • ICP • Others

  28. OSMOTHERAPY & HYPERTONIC SALINE • Use of Hypertonic Saline in cerebral edema and intracranial hypertension (critical care med; Quereshi et.al. 2000) • Treatment of refractory intracranial hypertension with 23.4% saline (30-60ml bolus every 6 hours) (Crit care med Suarez et.a.l 1998) •  Protocol •  Extreme Care

  29. PROTOCOL GUIDELINE FOR ICP CONTROL IN SEVERE HEAD INJURY PATIENTS • HYPERTONIC SALINE (3%) 0.5-1 ml/kg/hr (frequent S.Na to obtain desired S.Na conc. & intra vascular volume) • FUROSEMIDE 0.05 – 0.25 mg/kg/hr to obtain desired protocol. • MANNITOL bolus infusion 1/8 –1/2 gm/kg at 4-6 hrly intervals to obtain desired osmolality (Protocol 1985-1990, Critical Care Med, 2000)

  30. Venticulostomy

  31. AIM OF METICULOUS BP CONTROL Cerebral perfusion pressure ( MABP – ICP) to be kept at or around 70 mm Hg against an elevated ICP (Rosner & Johnson – 1995)

  32. ARTERIAL BLOOD PRESSURE (BP) MANAGEMENT AIM:To keep BP within limits of auto-regulation. continuous BP measurement. BENEFITS OBTAINED: Avoidance of lowered BP (Ischaemia  ed) Avoidance of elevated BP(Hematoma  ed , Increased risk of ICH in Thrombolysis. Guiding hypervolemic / induced hypertension (in SAH to prevent vasospasm in critical vascular stenosis). Helping in early detection of autonomic instability.

  33. ISSUE OF BP CONTROL (Adams, 1996) • MONITOR BP FOR 24 HOURS Every 15 Minutes X 2 hrs Every 30 Minutes X 6 hrs Every hour X 18 hrs

  34. Is the patient Hypertensive? • What to do? Type of fluids Type of vasopressors Amount of fluids (heart failure ? In association) • Should we induce Hypertension? Yes, when possibility of intra or extra cranial arterial stenosis.

  35. BP Control

  36. Drugs for BP control • Urapidil (0.1-1.5 mg/kg/hr) • Nicardipine (1-1.5 mg/hr) • Esmolol (0.05-0.4 mg/kg/hr) • Labetolol • Hydralazine • Diltiazem • Verapamil • Clonidine

  37. Is the patient hypertensive?(contd.) • Raised BP is a defensive auto regulatory process in acute setting • Hypertension alone in the absence of excessive CBF or myocardial dysfunction should not be treated because it often reflects homeostatic response to acute cerebral ischemia • Previously HTN – 180/100-105 • Mild HTN – 160-180/90-100 • BP 220/120 demand therapeutic intervention but the fall in BP should be gradual

  38. Issue of high BP & its control • Diastolic BP  140 mm Hg (Two readings 5 min apart) Nitroprusside 0.5 to 10  g /kg/min till DBP is lowered by 20%. • Systolic BP  230 mm Hg (± DBP 121-140 mm Hg)  Labetalol 20 mg over 2 min (Dose may be doubled) repeat or double every 10 min till 150 mg given or BP controlled.  If not switch back to Nitroprusside.  If SBP is 180 – 230 mm Hg and/or DBP is 105-120 mm Hg at two readings 5-10 min apart, give Labetalol 10 mg IV over 2 min. The dose may be repeated at 20 min upto 150 mg.  Monitor BP every 15 min to prevent hypotension. • Avoid sublingual nifedipine

  39. Analgesia & Sedation

  40. Infarcts • Thrombolysis • Decompressive Surgery – considered within 8 hours if ICP cannot be controlled conventionally, after careful discussion. (massive hemispheric strokes, malignant MCA infarcts & high ICP)

  41. Surgery • ICH – large >30 ml, close to surface with high ICP may be treated surgically (clot removal)

  42. Poor Predictors of Outcome • Absence of Pupillary reflexes at any time • Absence of corneal reflex • Absence of Motor response to pain at day 3 • Absence of oculo-vestibular response at 24hrs • Post-anoxic status/myoclonic status epilepticus • EEG – burst supression

More Related